Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.64 |
| ▸ | LMNA | P02545 | 4/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | USP2 | O75604 | 1/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 2/20 | 0.53 |
| ▸ | APP | P05067 | 1/20 | 0.53 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4196772 | 0.86 | L3MBTL1 (0.68) | KMT2ALMNATDP1L3MBTL1MAPK1 | |
| SCHEMBL25009812 | 0.85 | L3MBTL1 (0.76) | KMT2ALMNATDP1L3MBTL1MAPK1 | |
| SCHEMBL30556174 | 0.85 | L3MBTL1 (0.76) | KMT2ALMNATDP1L3MBTL1MAPK1 | |
| SCHEMBL14741028 | 0.84 | LMNA (0.66) | KMT2ALMNATDP1L3MBTL1MAPK1 | |
| SCHEMBL17978281 | 0.84 | KMT2A (0.66) | KMT2ALMNATDP1L3MBTL1MAPK1 | |
| SCHEMBL4204510 | 0.83 | L3MBTL1 (0.73) | KMT2ALMNATDP1L3MBTL1MAPK1 | |
| SCHEMBL837646 | 0.82 | LMNA (0.64) | KMT2ALMNATDP1L3MBTL1MAPK1 | |
| SCHEMBL21243071 | 0.82 | LMNA (0.82) | KMT2ALMNATDP1L3MBTL1MAPK1 | |
| Ethyl Nicotinate SCHEMBL8164637 | 0.82 | L3MBTL1 (0.71) | KMT2ALMNATDP1L3MBTL1MAPK1 | |
| Ethyl Nicotinate SCHEMBL1330922 | 0.82 | L3MBTL1 (0.71) | KMT2ALMNATDP1L3MBTL1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011056126-A1 | NOVEL 1,3-OXAZOLIDINE COMPOUNDS AND THEIR USE AS RENIN INHIBITORS | NOVADEX PHARMACEUTICALS AB (SE) | 2011-05-12 | — | — | WO | claimed |
| EP-0532446-A1 | Use of xanthines in the treatment or prevention of hypeoglycemia | NOVO NORDISK A/S (DK) | 1993-03-17 | — | — | EP | claimed |
| WO-1993003727-A1 | USE OF CERTAIN XANTHINE DERIVATIVES AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS FOR THE MANUFACTURE OF A MEDICAMENT USEFUL FOR COUNTERACTING HYPOCLYCAEMIA | NOVO NORDISK A/S (DK) | 1993-03-04 | — | — | WO | claimed |
| WO-2024080351-A1 | LIQUID CRYSTAL ALIGNING AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT | 日産化学株式会社 | 2024-04-18 | — | — | WO | disclosed |
| WO-2024058164-A1 | LIQUID CRYSTAL ALIGNING AGENT AND LIQUID CRYSTAL DISPLAY ELEMENT | 日産化学株式会社 | 2024-03-21 | — | — | WO | disclosed |
| WO-2023136269-A1 | LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT | 日産化学株式会社 | 2023-07-20 | — | — | WO | disclosed |
| WO-2023085390-A1 | LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT | 日産化学株式会社 | 2023-05-19 | — | — | WO | disclosed |
| US-20210371664-A1 | LIQUID CRYSTAL ALIGNING AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT | NISSAN CHEMICAL CORPORATION (JP) | 2021-12-02 | — | — | US | disclosed |
| US-11111387-B2 | Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2021-09-07 | — | — | US | disclosed |
| WO-2020145175-A1 | LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT | 日産化学株式会社 | 2020-07-16 | — | — | WO | disclosed |
| US-20180244922-A1 | LIQUID CRYSTAL ALIGNING AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2018-08-30 | — | — | US | disclosed |
| WO-1993003727-A1 | USE OF CERTAIN XANTHINE DERIVATIVES AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS FOR THE MANUFACTURE OF A MEDICAMENT USEFUL FOR COUNTERACTING HYPOCLYCAEMIA | NOVO NORDISK A/S (DK) | 1993-03-04 | — | — | WO | disclosed |
| EP-0508549-A2 | New triazolopyrimidine and pyrazolopyrimidine derivatives useful for treating cachexia | SANKYO COMPANY LIMITED (JP) | 1992-10-14 | — | — | EP | disclosed |
| US-5086057-A | METHOD OF TREATING CACHEXIA AND CERTAIN NEW COMPOUNDS FOR USE IN THIS METHOD | SANKYO COMPANY LIMITED (JP) | 1992-02-04 | — | — | US | disclosed |
| US-5055479-A | For enhancing activity of lipoprotein lipase enzymes | SANKYO COMPANY, LIMITED (JP) | 1991-10-08 | — | — | US | disclosed |
| EP-0347252-A2 | Method of treating cachexia and certain new compounds for use in this method | SANKYO COMPANY LIMITED (JP) | 1989-12-20 | — | — | EP | disclosed |
| US-4808620-A | ANTIINFLAMMATORY, ANALGESICS, ANTIPYRETIC, ANTIALLERGENS, ANTIARTHRITIC, ANTIRHEUMATIC AGENTS | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1989-02-28 | — | — | US | disclosed |
| EP-0254241-A1 | Pyrazolopyridine compounds, their preparation and use | Yoshitomi Pharmaceutical Industries, Ltd. (JP) | 1988-01-27 | — | — | EP | disclosed |
| EP-0099438-A1 | 2-Functionalised diaryl as-triazines useful in therapy | PIERRE FABRE S.A. (FR) | 1984-02-01 | — | — | EP | disclosed |
| EP-0053681-A1 | B-Nicotinoyloxyethyl nicotinic S-acid ester and its preparation via 2-Mercaptoethyl nicotinate | Tauro, Celesio Sonnino (IT) | 1982-06-16 | — | — | EP | disclosed |